Exact Mass: 404.2064

Exact Mass Matches: 404.2064

Found 61 metabolites which its exact mass value is equals to given mass value 404.2064, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

Flunarizine

1-[bis(4-fluorophenyl)methyl]-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine

C26H26F2N2 (404.2064)


Flunarizine is a selective calcium entry blocker with calmodulin binding properties and histamine H1 blocking activity. It is effective in the prophylaxis of migraine, occlusive peripheral vascular disease, vertigo of central and peripheral origin, and as an adjuvant in the therapy of epilepsy. N - Nervous system > N07 - Other nervous system drugs > N07C - Antivertigo preparations > N07CA - Antivertigo preparations C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker Flunarizine is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine is a D2 dopamine receptor antagonist. Flunarizine shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].

   

1-[Bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-enyl)piperazine

1-[bis(4-fluorophenyl)methyl]-4-(3-phenylprop-2-en-1-yl)piperazine

C26H26F2N2 (404.2064)


   

1-(Dimethylarsinoyl)-2,5,8,11,14,17-heneicosahexaene

1-(Dimethylarsinoyl)-2,5,8,11,14,17-heneicosahexaene

C23H37AsO (404.206)


   
   
   
   
   
   
   
   
   
   
   

Flunarizine

Flunarizine

C26H26F2N2 (404.2064)


N - Nervous system > N07 - Other nervous system drugs > N07C - Antivertigo preparations > N07CA - Antivertigo preparations C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker CONFIDENCE Reference Standard (Level 1); Source flunarizine_30102013_HCD15_pos.txt Flunarizine is a potent dual Na+/Ca2+ channel (T-type) blocker. Flunarizine is a D2 dopamine receptor antagonist. Flunarizine shows anticonvulsive and antimigraine activity, and peripheral vasodilator effects[1][2][3][4][5].

   

Ala Ala Phe Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C20H28N4O5 (404.206)


   

Ala Ala Pro Phe

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C20H28N4O5 (404.206)


   

Ala Phe Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H28N4O5 (404.206)


   

Ala Phe Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H28N4O5 (404.206)


   

Ala Pro Ala Phe

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-phenylpropanoic acid

C20H28N4O5 (404.206)


   

Ala Pro Phe Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]propanoic acid

C20H28N4O5 (404.206)


   

Phe Ala Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]propanoyl]pyrrolidine-2-carboxylic acid

C20H28N4O5 (404.206)


   

Phe Ala Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C20H28N4O5 (404.206)


   

Phe Pro Ala Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]propanoic acid

C20H28N4O5 (404.206)


   
   
   
   
   
   

Pro Ala Ala Phe

(2S)-3-phenyl-2-[(2S)-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C20H28N4O5 (404.206)


   

Pro Ala Phe Ala

(2S)-2-[(2S)-3-phenyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C20H28N4O5 (404.206)


   

Pro Phe Ala Ala

(2S)-2-[(2S)-2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C20H28N4O5 (404.206)


   
   
   
   

1-dimethylarsinoyl-(2Z,5Z, 8Z,11Z,14Z,17Z)-heneicosahexaene

1-dimethylarsinoyl-(2Z,5Z, 8Z,11Z,14Z,17Z)-heneicosahexaene

C23H37OAs (404.206)


   
   

L-Leucyl-L-tryptophyl-L-serine

L-Leucyl-L-tryptophyl-L-serine

C20H28N4O5 (404.206)


   

Pyroglutamylphenylalanyllysine

Pyroglutamylphenylalanyllysine

C20H28N4O5 (404.206)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

1-dimethylarsinoyl-(2Z,5Z, 8Z,11Z,14Z,17Z)-heneicosahexaene

1-dimethylarsinoyl-(2Z,5Z, 8Z,11Z,14Z,17Z)-heneicosahexaene

C23H37AsO (404.206)


   
   

2,10,17-trimethyl-3,11,16,20-tetraazatricyclo[11.7.1.0¹⁴,¹⁹]henicosa-3,5,11,14(19),15,17-hexaene-1,4,7,12,15-pentol

2,10,17-trimethyl-3,11,16,20-tetraazatricyclo[11.7.1.0¹⁴,¹⁹]henicosa-3,5,11,14(19),15,17-hexaene-1,4,7,12,15-pentol

C20H28N4O5 (404.206)


   

5-(4-amino-2-hydroxy-6-methylpyridin-3-yl)-6,11,14-trihydroxy-2,8-dimethyl-1,7-diazacyclotetradeca-1(14),6,12-trien-3-one

5-(4-amino-2-hydroxy-6-methylpyridin-3-yl)-6,11,14-trihydroxy-2,8-dimethyl-1,7-diazacyclotetradeca-1(14),6,12-trien-3-one

C20H28N4O5 (404.206)


   

(1r,2s,5e,7s,10s,13s)-2,10,17-trimethyl-3,11,16,20-tetraazatricyclo[11.7.1.0¹⁴,¹⁹]henicosa-3,5,11,14(19),15,17-hexaene-1,4,7,12,15-pentol

(1r,2s,5e,7s,10s,13s)-2,10,17-trimethyl-3,11,16,20-tetraazatricyclo[11.7.1.0¹⁴,¹⁹]henicosa-3,5,11,14(19),15,17-hexaene-1,4,7,12,15-pentol

C20H28N4O5 (404.206)


   

(2s,5s,8s,11s,12e)-5-(4-amino-2-hydroxy-6-methylpyridin-3-yl)-6,11,14-trihydroxy-2,8-dimethyl-1,7-diazacyclotetradeca-1(14),6,12-trien-3-one

(2s,5s,8s,11s,12e)-5-(4-amino-2-hydroxy-6-methylpyridin-3-yl)-6,11,14-trihydroxy-2,8-dimethyl-1,7-diazacyclotetradeca-1(14),6,12-trien-3-one

C20H28N4O5 (404.206)